SEATTLE GENETICS INC (76) | Uncategorized (7)
Recent Contracts
-
Form of Letter Agreement, dated March 12, 2023
(Filed With SEC on March 13, 2023)
-
Amendment to Joint Commercialization Agreement between Seagen Inc. and Agensys, Inc. effective January 1, 2020
(Filed With SEC on July 29, 2021)
-
Letter Agreement Regarding Royalty between the University of Miami and Seagen Inc. (f/k/a
(Filed With SEC on July 29, 2021)
-
Joint Commercialization Agreement dated October 19, 2020 between Genmab A/S and Seagen Inc. (f.k.a. Seattle Genetics Inc.)
(Filed With SEC on February 12, 2021)
-
Amendment No. 1
(Filed With SEC on July 31, 2020)
-
Description of Securities of Seattle Genetics, Inc
(Filed With SEC on February 6, 2020)
-
Joint Commercialization Agreement dated October 20, 2018 between Seattle Genetics, Inc. and Agensys, Inc
(Filed With SEC on July 16, 2019)